Celyad Oncology’s Post

📢 Attention: still chance ⌚ to sign up for this upcoming webinar! ❗ Don't miss how #JamesMatcham and #MichaelFossler will delve into the key objectives of early oncology development, focusing on the estimation of the recommended Phase 2 dose (RP2D) and the identification of optimal patient populations for further research. 👇 Key Topics: - Dose Escalation Design Options - Basket Study Design Options - PK/PD Modelling for identifying the RP2D #cytel #clinicaldevelopment #oncology

Are you aware of the recent implementation of the EU Clinical Trials Regulation No 536/2014 and how that will affect your oncology program? Find out in my team members’ blog: https://bit.ly/3Yws1UO

Are you aware of the recent implementation of the EU Clinical Trials Regulation No 536/2014 and how that will affect your oncology program? Find out in my team members’ blog: https://bit.ly/4d8eHdy

In this episode of Oncology Today with Dr Neil Love, you can hear the perspectives Dr Petros Grivas shares on research with and ongoing studies evaluating available and investigational agents and strategies for patients with UBC.

Listen to what new data from the #ASCO24 congress is likely to impact the field of upper GI oncology. With experts Sam Klempner and Lizzy Smyth. Watch this space for a summary of the highlights during the congress. #MedEd #MedEd #MedicalEducation

Which #cancers are HCPs talking about online at American Society of Clinical Oncology (ASCO) ? Presentations on studies such as the #CROWN and #PALOMA-3 trials are causing the #lungcancer conversation to dominate. Watch this space for more updates from the next three days of #ASCO24! #WhatHCPsThink

Today, we announced a poster presentation at the American Society of Clinical Oncology (ASCO)) annual meeting highlighting interim results from the ongoing Phase 1 ELiPSE-1 study of CNTY-101 in relapsed or refractory (R/R) #lymphoma. The poster showcases CNTY-101’s continued encouraging preliminary efficacy and manageable safety profile for with no observed DLTs or GvHD. Learn more: https://bit.ly/3RaEI3k #ASCO2024

Satej Bhogill and Catherine Chintala, PMP share what they enjoyed most at this year's #ASCO24 conference. Learn more about MERIT's oncology experience and solutions at https://lnkd.in/gD7rC9zQ #MERITCRO #YourClinicalEndpointExpert #imagingsolutions #clinicaltrials #clincialresearch #oncologytrials

This is how it all came together! Two days of transformative dialogue improving the process of clinical trials 🌍💬 #HealthcareInnovation #PatientExperience #inclusion #fda #GlobalCollaboration #clinicaltrials

🧡Hosted by #SyneosHealth and the Society for Clinical Research Sites (SCRS), our latest on-demand webinar explores the complexities and paths towards enhanced diversity in oncology trials at the site level.   Watch the full webinar here: https://lnkd.in/dXBXVQFd #SyneosHealthLife #WorkHereMattersEverywhere #ClinicalCareers #ClinicalSolutions #DiversityinOncologyTrials